ES2153081T3 - Forma cristalina alternativa de tazofelona((+,-)-5-((3,5-bis(1,1-dimetiletil)-4-hidroxifenil)metil)-4-tiazolidinona). - Google Patents
Forma cristalina alternativa de tazofelona((+,-)-5-((3,5-bis(1,1-dimetiletil)-4-hidroxifenil)metil)-4-tiazolidinona).Info
- Publication number
- ES2153081T3 ES2153081T3 ES96306336T ES96306336T ES2153081T3 ES 2153081 T3 ES2153081 T3 ES 2153081T3 ES 96306336 T ES96306336 T ES 96306336T ES 96306336 T ES96306336 T ES 96306336T ES 2153081 T3 ES2153081 T3 ES 2153081T3
- Authority
- ES
- Spain
- Prior art keywords
- tazofelona
- bis
- methyl
- crystal form
- tiazolidinona
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/14—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
Abstract
LA INVENCION PROPORCIONA UNA NUEVA FORMA CRISTALINA, FORMA II DE (+,-)-5-{[3,5-BIS(1,1-DIMETILETIL)-4-HIDROXIFENIL] METIL}-4TIAZOLIDINONA, QUE PRESENTA UN PATRON DE DIFRACCION DE POLVO DE RAYOS X CON SEPARACIONES D A 5,64; 5,16; 4,90; 4,66; Y 4,49 AMSTRONGS. ES UTIL PARA EL TRATAMIENTO DE LA INFLAMACION, LA ENFERMEDAD INFLAMATORIA DEL COLON, ALERGIAS, ARTRITIS E HIPOGLICEMIA EN SU NUEVA FORMA FISICA; TAMBIEN SE PROPORCIONAN COMPOSICIONES FARMACEUTICAS QUE CONTIENEN DICHA FORMA NUEVA. SE DESCRIBE UN PROCEDIMIENTO DE PREPARACION DE LA FORMA II DE LA TAZOFELONA.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US335695P | 1995-09-07 | 1995-09-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2153081T3 true ES2153081T3 (es) | 2001-02-16 |
Family
ID=21705475
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES96306336T Expired - Lifetime ES2153081T3 (es) | 1995-09-07 | 1996-09-02 | Forma cristalina alternativa de tazofelona((+,-)-5-((3,5-bis(1,1-dimetiletil)-4-hidroxifenil)metil)-4-tiazolidinona). |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP0761656B1 (es) |
| JP (1) | JPH11514978A (es) |
| KR (1) | KR19990044453A (es) |
| CN (1) | CN1082958C (es) |
| AR (2) | AR003484A1 (es) |
| AT (1) | ATE198476T1 (es) |
| AU (1) | AU716684B2 (es) |
| BR (1) | BR9610201A (es) |
| CA (1) | CA2231132A1 (es) |
| CO (1) | CO4750653A1 (es) |
| CZ (1) | CZ68098A3 (es) |
| DE (1) | DE69611407T2 (es) |
| DK (1) | DK0761656T3 (es) |
| EA (1) | EA000258B1 (es) |
| ES (1) | ES2153081T3 (es) |
| GR (1) | GR3035656T3 (es) |
| HU (1) | HUP9901458A3 (es) |
| IN (1) | IN182320B (es) |
| MY (1) | MY132351A (es) |
| NO (1) | NO309719B1 (es) |
| NZ (1) | NZ316810A (es) |
| PE (1) | PE23298A1 (es) |
| PL (1) | PL325602A1 (es) |
| PT (1) | PT761656E (es) |
| SI (1) | SI0761656T1 (es) |
| TR (1) | TR199800398T1 (es) |
| TW (1) | TW460471B (es) |
| WO (1) | WO1997009320A1 (es) |
| ZA (1) | ZA967422B (es) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US538690A (en) * | 1895-05-07 | Automatic watering-trough for animals | ||
| ZA9010041B (en) * | 1989-12-21 | 1992-08-26 | Lilly Co Eli | Compounds for treating inflammatory bowel disease |
| US5216002A (en) * | 1989-12-21 | 1993-06-01 | Eli Lilly And Company | Method of treating inflammatory bowel disease |
-
1996
- 1996-09-02 TW TW085110670A patent/TW460471B/zh active
- 1996-09-02 AT AT96306336T patent/ATE198476T1/de not_active IP Right Cessation
- 1996-09-02 AR ARP960104199A patent/AR003484A1/es not_active Application Discontinuation
- 1996-09-02 EP EP96306336A patent/EP0761656B1/en not_active Expired - Lifetime
- 1996-09-02 SI SI9630287T patent/SI0761656T1/xx unknown
- 1996-09-02 PT PT96306336T patent/PT761656E/pt unknown
- 1996-09-02 AR ARP960104198A patent/AR003483A1/es not_active Application Discontinuation
- 1996-09-02 DK DK96306336T patent/DK0761656T3/da active
- 1996-09-02 PE PE1996000641A patent/PE23298A1/es not_active Application Discontinuation
- 1996-09-02 DE DE69611407T patent/DE69611407T2/de not_active Expired - Fee Related
- 1996-09-02 ES ES96306336T patent/ES2153081T3/es not_active Expired - Lifetime
- 1996-09-02 IN IN1563CA1996 patent/IN182320B/en unknown
- 1996-09-02 ZA ZA9607422A patent/ZA967422B/xx unknown
- 1996-09-03 CA CA002231132A patent/CA2231132A1/en not_active Abandoned
- 1996-09-03 PL PL96325602A patent/PL325602A1/xx unknown
- 1996-09-03 NZ NZ316810A patent/NZ316810A/xx unknown
- 1996-09-03 CN CN96197822A patent/CN1082958C/zh not_active Expired - Fee Related
- 1996-09-03 WO PCT/US1996/014132 patent/WO1997009320A1/en not_active Application Discontinuation
- 1996-09-03 CZ CZ98680A patent/CZ68098A3/cs unknown
- 1996-09-03 HU HU9901458A patent/HUP9901458A3/hu unknown
- 1996-09-03 KR KR1019980701701A patent/KR19990044453A/ko not_active Application Discontinuation
- 1996-09-03 JP JP9511339A patent/JPH11514978A/ja active Pending
- 1996-09-03 TR TR1998/00398T patent/TR199800398T1/xx unknown
- 1996-09-03 AU AU69127/96A patent/AU716684B2/en not_active Ceased
- 1996-09-03 EA EA199800275A patent/EA000258B1/ru not_active IP Right Cessation
- 1996-09-03 BR BR9610201A patent/BR9610201A/pt not_active Application Discontinuation
- 1996-09-04 MY MYPI96003663A patent/MY132351A/en unknown
- 1996-09-05 CO CO96047346A patent/CO4750653A1/es unknown
-
1998
- 1998-03-03 NO NO980913A patent/NO309719B1/no not_active IP Right Cessation
-
2001
- 2001-03-29 GR GR20010400506T patent/GR3035656T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT861666E (pt) | Composicao farmaceutica para utilizacao no tratamento da diabetes | |
| CY1105653T1 (el) | Στεροειδεις σαπωνινες για τη θεραπεια της νοσου alzheimer | |
| NO953657D0 (no) | Nytt farmasöytisk produkt | |
| NO982302D0 (no) | Farmas÷ytisk sammensetning | |
| CL2010000018A1 (es) | Fragmentos de peptido amiloide beta(ab) ab 1-7 y ab 3-7 ligados a un peptido portador, composicion farmaceutica que lo comprende y su uso para tratar la enfermedad de alzheimer | |
| AR008462A1 (es) | COMPOSICIoN FARMACÉUTICA QUE COMPRENDE OLANZAPINA Y CLORHIDRATO DE FLUOXETINA Y USO DE DICHA COMPOSICIoN PARA LA FABRICACIoN DE UN MEDICAMENTO. | |
| SE9802729D0 (sv) | Novel Compounds | |
| DE69300913D1 (de) | Polymorph Terazosin und pharmazeutische Zusammenstellung. | |
| BR0114344A (pt) | Retinóides para o tratamento de enfisema | |
| DE69632588D1 (de) | Gegen vandalismus beständiger waschraumproduktspender | |
| ES2177024T3 (es) | Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer. | |
| ES2153081T3 (es) | Forma cristalina alternativa de tazofelona((+,-)-5-((3,5-bis(1,1-dimetiletil)-4-hidroxifenil)metil)-4-tiazolidinona). | |
| BR9812773A (pt) | "alfa-amino-epsilon-caprolactamas policìclicas e compostos relacionados" | |
| BG108452A (en) | Tablet comprising cetirizine and pseudoephedrine | |
| ES2165496T3 (es) | Inhibidores triciclicos de metaloproteinasas matriciales. | |
| ES2054115T3 (es) | Fenilhidrazonas, su fabricacion y medicamentos y productos cosmeticos fabricados a partir de estas. | |
| PT939083E (pt) | Complexos de ferro-succinilcaseina procedimento para sua preparacao e suas composicoes farmaceuticas | |
| DZ1965A1 (fr) | Composition pharmaceutique nouvelle. | |
| FR2702654B1 (fr) | Produit cosmétique destiné à raffermir l'épiderme. | |
| FI964113A (fi) | Lääkekoostumus hoitamaan tardiivia dyskinesiaa ja sen käyttö | |
| BR9808866A (pt) | Moléculas retinóicas relacionadas à inibição da superprodução de endotelina-1 em doenças | |
| PT101460A (pt) | Forma purificada de estreptograminas, sua preparacao e composicoes farmaceuticas que a contaem | |
| FR2807944B1 (fr) | Utilisation de l'anethole-dithiolethione dans la prevention et le traitement de la tenotoxicite induite par un medicament | |
| FR2710083B1 (fr) | Ensemble socle et panneau souple de signalisation temporaire notamment routière. | |
| MX9102627A (es) | Composicion farmaceutica de dobutamina para administracion transdermica. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 761656 Country of ref document: ES |